Subscribe To
Oncocyte announces 1-for-20 reverse stock split
IRVINE, Calif., July 24, 2023 (GLOBE NEWSWIRE) — Oncocyte Corporation (Nasdaq: OCX) (the “Company�...
July 24, 2023, 5:35 pm
Iovance biotherapeutics reports inducement grants under nasdaq listing rule 5635(c)(4)
SAN CARLOS, Calif., July 21, 2023 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, de...
July 21, 2023, 9:34 pm
Turnstone biologics corp. announces pricing of upsized initial public offering
SAN DIEGO, July 20, 2023 (GLOBE NEWSWIRE) — Turnstone Biologics Corp. (“Turnstone” or the “Company”) (Nasdaq: TSBX), a clinical-stage biotec...
July 21, 2023, 6:15 am
cytek biosciences to report second quarter 2023 financial results on august 8, 2023
FREMONT, Calif., July 20, 2023 (GLOBE NEWSWIRE) — cytek Biosciences, Inc. (Nasdaq: CTKB), a leading c...
July 20, 2023, 9:26 pm
cytek biosciences to report second quarter 2023 financial results on august 8, 2023
FREMONT, Calif., July 20, 2023 (GLOBE NEWSWIRE) -- cytek Biosciences, Inc. (Nasdaq: CTKB), a leading ce...
July 20, 2023, 5:26 pm
Veracyte to release second quarter 2023 financial results on august 8, 2023
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT) announced today that it wil...
July 19, 2023, 5:00 pm
Incyte's (incy) opzelura meets goal in phase iii pediatric study
Incyte's (INCY) Opzelura (ruxolitinib cream) meets the primary endpoint in a phase III study in childre...
July 12, 2023, 12:34 pm
Incyte skin disease drug for children meets main goal in late-stage study
Incyte Corp said on Tuesday its experimental drug to treat a skin condition in children between the age...
July 11, 2023, 4:23 pm
Yourgene jumps 143% on novacyt £16.7m knock-out bid
Novacyt SA (AIM:NCYT, OTC:NVYTF, EPA:ALNOV) is swooping to buy Yourgene Health PLC in a deal that values the latter at £16.7 million, or a 168% prem...
July 3, 2023, 4:40 am
Iovance biotherapeutics to host virtual roundtable with key opinion leaders to discuss melanoma treatment landscape
Investor Conference Call and Webcast on June 26 at 5:00 p.m. ET SAN CARLOS, Calif., June 20, 2023 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (...
June 20, 2023, 11:01 am
Helocyte announces $3.22 million grant from the national cancer institute for triplex phase 2 clinical trial program
Multicenter randomized placebo-controlled trials will evaluate the ability of the cytomegalovirus (“CMV”) vaccine to enhance protective virus-spec...
June 15, 2023, 12:00 pm
Wall street analysts think vaxcyte, inc. (pcvx) could surge 33.33%: read this before placing a bet
The average of price targets set by Wall Street analysts indicates a potential upside of 33.3% in Vaxcyte...
May 29, 2023, 11:05 am
Heather prichard sells 23,402 shares of humacyte inc (huma)
On May 25, 2023, Heather Prichard, the Chief Operating Officer (COO) of Humacyte Inc ( HUMA , Financial...
May 27, 2023, 2:03 am
Vaxcyte: positive phase 2 results elevate confidence in vax-24's potential
Vaxcyte is emerging as a leader in vaccine innovation, leveraging high-fidelity vaccines to combat bact...
May 17, 2023, 8:20 am
cytek biosciences, inc. (ctkb) q1 2023 earnings call transcript
cytek Biosciences, Inc. (NASDAQ:CTKB ) Q1 2023 Earnings Conference Call May 9, 2023 4:30 PM ET Company ...
May 13, 2023, 5:00 pm
Why shares of cytek biosciences dropped this week
cytek focuses on cell analysis primarily for research purposes. The company joined the S&P SmallCap 600...
May 12, 2023, 3:41 pm
Humacyte, inc. (huma) reports q1 loss, misses revenue estimates
Humacyte, Inc. (HUMA) came out with a quarterly loss of $0.22 per share in line with the Zacks Consensu...
May 12, 2023, 9:56 am
Oncocyte reports first quarter 2023 financial results
Nearing Manufacturing Start Up of First Kitted Product IRVINE, Calif., May 11, 2023 (GLOBE NEWSWIRE) — Oncoc...
May 11, 2023, 12:00 pm
Maxcyte, inc. (mxct) reports q1 loss, lags revenue estimates
Maxcyte, Inc. (MXCT) came out with a quarterly loss of $0.11 per share in line with the Zacks Consensus...
May 10, 2023, 6:59 pm
cytek biosciences, inc. (ctkb) reports break-even earnings for q1
cytek Biosciences, Inc. (CTKB) reported break-even quarterly earnings per share versus the Zacks Consen...
May 9, 2023, 7:07 pm